Skip to main content
Erschienen in: Der Schmerz 6/2016

02.11.2016 | Opioide | CME

Schmerzmedikation in der Schwangerschaft

verfasst von: Dr. med. S. Hultzsch, C. Schaefer

Erschienen in: Der Schmerz | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Bei einer analgetischen Therapie in der Schwangerschaft sind einige Einschränkungen zu berücksichtigen. Paracetamol ist das Mittel der Wahl in jeder Phase der Schwangerschaft bei leichten oder mittleren Schmerzen. Ibuprofen ist das nichtsteroidale Analgetikum der Wahl, wobei diese Substanzen nach der 28. Schwangerschaftswoche wegen der Gefahr eines vorzeitigen Ductusverschlusses und fetaler Nierenfunktionsstörungen kontraindiziert sind. Bei starken Schmerzen können auch Opioide eingesetzt werden, allerdings muss bei peripartaler Anwendung mit Atemdepression und Anpassungsstörungen beim Neugeborenen gerechnet werden, bei einer Dauertherapie bis zum Ende der Schwangerschaft mit Entzugserscheinungen. Migräne kann mit Sumatriptan behandelt werden. Antiepileptika sollten bei Schwangeren nicht angewendet werden, da ein teratogenes Risiko meist nicht auszuschließen ist. Gut untersuchte Antidepressiva wie Amitriptylin können dagegen bei entsprechender Schmerzindikation verwendet werden.
Literatur
1.
Zurück zum Zitat Schaefer C, Spielmann H, Vetter K et al (2012) Arzneimittel in Schwangerschaft und Stillzeit. Elsevier, Urban & Fischer, Amsterdam, München, Jena Schaefer C, Spielmann H, Vetter K et al (2012) Arzneimittel in Schwangerschaft und Stillzeit. Elsevier, Urban & Fischer, Amsterdam, München, Jena
2.
Zurück zum Zitat Feldkamp ML, Meyer RE, Krikov S et al (2010) Acetaminophen use in pregnancy and risk of birth defects: Findings from the National Birth Defects Prevention Study. Obstet Gynecol 115:109–115CrossRefPubMed Feldkamp ML, Meyer RE, Krikov S et al (2010) Acetaminophen use in pregnancy and risk of birth defects: Findings from the National Birth Defects Prevention Study. Obstet Gynecol 115:109–115CrossRefPubMed
3.
Zurück zum Zitat Kristensen DM, Hass U, Lesne L et al (2011) Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 26:235–244CrossRefPubMed Kristensen DM, Hass U, Lesne L et al (2011) Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 26:235–244CrossRefPubMed
4.
Zurück zum Zitat Rebordosa C, Kogevinas M, Sorensen HT et al (2008) Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: A birth cohort study. Int J Epidemiol 37:583–590CrossRefPubMed Rebordosa C, Kogevinas M, Sorensen HT et al (2008) Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: A birth cohort study. Int J Epidemiol 37:583–590CrossRefPubMed
5.
Zurück zum Zitat Liew Z, Ritz B, Rebordosa C et al (2014) Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 168:313–320CrossRefPubMed Liew Z, Ritz B, Rebordosa C et al (2014) Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 168:313–320CrossRefPubMed
6.
Zurück zum Zitat Da Silva Dal Pizzol T, Schuler-Faccini L, Mengue SS et al (2009) Dipyrone use during pregnancy and adverse perinatal events. Arch Gynecol Obstet 279:293–297CrossRefPubMed Da Silva Dal Pizzol T, Schuler-Faccini L, Mengue SS et al (2009) Dipyrone use during pregnancy and adverse perinatal events. Arch Gynecol Obstet 279:293–297CrossRefPubMed
7.
Zurück zum Zitat Sharpe CR, Franco EL (1996) Use of dipyrone during pregnancy and risk of Wilms’ tumor. Brazilian Wilms’ Tumor Study Group. Epidemiology 7:533–535CrossRefPubMed Sharpe CR, Franco EL (1996) Use of dipyrone during pregnancy and risk of Wilms’ tumor. Brazilian Wilms’ Tumor Study Group. Epidemiology 7:533–535CrossRefPubMed
8.
Zurück zum Zitat Couto AC, Ferreira JD, Pombo-De-Oliveira MS et al (2015) Pregnancy, maternal exposure to analgesic medicines, and leukemia in Brazilian children below 2 years of age. Eur J Cancer Prev 24:245–252CrossRefPubMed Couto AC, Ferreira JD, Pombo-De-Oliveira MS et al (2015) Pregnancy, maternal exposure to analgesic medicines, and leukemia in Brazilian children below 2 years of age. Eur J Cancer Prev 24:245–252CrossRefPubMed
9.
Zurück zum Zitat Bar-Oz B, Clementi M, Di Giantonio E et al (2005) Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol 119:176–179CrossRefPubMed Bar-Oz B, Clementi M, Di Giantonio E et al (2005) Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol 119:176–179CrossRefPubMed
10.
Zurück zum Zitat Daniel S, Koren G, Lunenfeld E et al (2015) NSAIDs and spontaneous abortions – true effect or an indication bias? Br J Clin Pharmacol 80:750–754CrossRefPubMedPubMedCentral Daniel S, Koren G, Lunenfeld E et al (2015) NSAIDs and spontaneous abortions – true effect or an indication bias? Br J Clin Pharmacol 80:750–754CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Antonucci R, Zaffanello M, Puxeddu E et al (2012) Use of non-steroidal anti-inflammatory drugs in pregnancy: Impact on the fetus and newborn. Curr Drug Metab 13:474–490CrossRefPubMed Antonucci R, Zaffanello M, Puxeddu E et al (2012) Use of non-steroidal anti-inflammatory drugs in pregnancy: Impact on the fetus and newborn. Curr Drug Metab 13:474–490CrossRefPubMed
12.
Zurück zum Zitat Kozer E, Nikfar S, Costei A et al (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis. Am J Obstet Gynecol 187:1623–1630CrossRefPubMed Kozer E, Nikfar S, Costei A et al (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis. Am J Obstet Gynecol 187:1623–1630CrossRefPubMed
13.
Zurück zum Zitat Daniel S, Matok I, Gorodischer R et al (2012) Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J Rheumatol 39:2163–2169CrossRefPubMed Daniel S, Matok I, Gorodischer R et al (2012) Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J Rheumatol 39:2163–2169CrossRefPubMed
14.
Zurück zum Zitat Stika CS, Gross GA, Leguizamon G et al (2002) A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 187:653–660CrossRefPubMed Stika CS, Gross GA, Leguizamon G et al (2002) A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 187:653–660CrossRefPubMed
16.
Zurück zum Zitat Schnabel A, Hahn N, Muellenbach R et al (2011) Obstetric analgesia in German clinics. Remifentanil as alternative to regional analgesia. Anaesthesist 60:995–1001CrossRefPubMed Schnabel A, Hahn N, Muellenbach R et al (2011) Obstetric analgesia in German clinics. Remifentanil as alternative to regional analgesia. Anaesthesist 60:995–1001CrossRefPubMed
17.
Zurück zum Zitat Reynolds F (2011) Labour analgesia and the baby: Good news is no news. Int J Obstet Anesth 20:38–50CrossRefPubMed Reynolds F (2011) Labour analgesia and the baby: Good news is no news. Int J Obstet Anesth 20:38–50CrossRefPubMed
18.
Zurück zum Zitat Reynolds F (2010) The effects of maternal labour analgesia on the fetus. Best Pract Res Clin Obstet Gynaecol 24:289–302CrossRefPubMed Reynolds F (2010) The effects of maternal labour analgesia on the fetus. Best Pract Res Clin Obstet Gynaecol 24:289–302CrossRefPubMed
19.
Zurück zum Zitat Morrison CE, Dutton D, Howie H et al (1987) Pethidine compared with meptazinol during labour. A prospective randomised double-blind study in 1100 patients. Anaesthesia 42:7–14CrossRefPubMed Morrison CE, Dutton D, Howie H et al (1987) Pethidine compared with meptazinol during labour. A prospective randomised double-blind study in 1100 patients. Anaesthesia 42:7–14CrossRefPubMed
20.
Zurück zum Zitat Nezvalova-Henriksen K, Spigset O, Nordeng H (2011) Effects of codeine on pregnancy outcome: Results from a large population-based cohort study. Eur J Clin Pharmacol 67:1253–1261CrossRefPubMedPubMedCentral Nezvalova-Henriksen K, Spigset O, Nordeng H (2011) Effects of codeine on pregnancy outcome: Results from a large population-based cohort study. Eur J Clin Pharmacol 67:1253–1261CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Regan J, Chambers F, Gorman W et al (2000) Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG 107:570–572CrossRefPubMed Regan J, Chambers F, Gorman W et al (2000) Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG 107:570–572CrossRefPubMed
22.
Zurück zum Zitat Szabo AL (2013) Review article: Intrapartum neuraxial analgesia and breastfeeding outcomes: Limitations of current knowledge. Anesth Analg 116:399–405CrossRefPubMed Szabo AL (2013) Review article: Intrapartum neuraxial analgesia and breastfeeding outcomes: Limitations of current knowledge. Anesth Analg 116:399–405CrossRefPubMed
23.
Zurück zum Zitat Gouraud AA, Beyens MNB, Boyer MC et al (2010) First trimester exposure to tramadol: A prospective comparative study. Fundam Clin Pharmacol 24(Supl 1):90 Gouraud AA, Beyens MNB, Boyer MC et al (2010) First trimester exposure to tramadol: A prospective comparative study. Fundam Clin Pharmacol 24(Supl 1):90
24.
Zurück zum Zitat Kallen B, Reis M (2015) Use of tramadol in early pregnancy and congenital malformation risk. Reprod Toxicol 58:246–251CrossRefPubMed Kallen B, Reis M (2015) Use of tramadol in early pregnancy and congenital malformation risk. Reprod Toxicol 58:246–251CrossRefPubMed
25.
Zurück zum Zitat Mccarthy JJ (2012) Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus? J Matern Fetal Neonatal Med 25:109–112CrossRefPubMed Mccarthy JJ (2012) Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus? J Matern Fetal Neonatal Med 25:109–112CrossRefPubMed
26.
Zurück zum Zitat Kieviet N, Dolman KM, Honig A (2013) The use of psychotropic medication during pregnancy: How about the newborn? Neuropsychiatr Dis Treat 9:1257–1266CrossRefPubMedPubMedCentral Kieviet N, Dolman KM, Honig A (2013) The use of psychotropic medication during pregnancy: How about the newborn? Neuropsychiatr Dis Treat 9:1257–1266CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Mcelhatton PR, Garbis HM, Elefant E et al (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 10:285–294CrossRefPubMed Mcelhatton PR, Garbis HM, Elefant E et al (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 10:285–294CrossRefPubMed
28.
Zurück zum Zitat Wisner KL, Schaefer C (2015) 2.11 – Psychotropic drugs. In: Schaefer C, Peters P, Miller R (eds) Drugs During Pregnancy and Lactation, 3. Aufl. Academic Press, San Diego, S 293–339CrossRef Wisner KL, Schaefer C (2015) 2.11 – Psychotropic drugs. In: Schaefer C, Peters P, Miller R (eds) Drugs During Pregnancy and Lactation, 3. Aufl. Academic Press, San Diego, S 293–339CrossRef
29.
Zurück zum Zitat Lassen D, Ennis ZN, Damkier P (2015) First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: A systematic review. Basic Clin Pharmacol Toxicol. doi:10.1111/bcpt.12497 PubMed Lassen D, Ennis ZN, Damkier P (2015) First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: A systematic review. Basic Clin Pharmacol Toxicol. doi:10.​1111/​bcpt.​12497 PubMed
30.
Zurück zum Zitat Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton
31.
Zurück zum Zitat Kallen B, Nilsson E, Otterblad Olausson P (2011) Delivery outcome after maternal use of drugs for migraine: A register study in Sweden. Drug Saf 34:691–703CrossRefPubMed Kallen B, Nilsson E, Otterblad Olausson P (2011) Delivery outcome after maternal use of drugs for migraine: A register study in Sweden. Drug Saf 34:691–703CrossRefPubMed
Metadaten
Titel
Schmerzmedikation in der Schwangerschaft
verfasst von
Dr. med. S. Hultzsch
C. Schaefer
Publikationsdatum
02.11.2016

Weitere Artikel der Ausgabe 6/2016

Der Schmerz 6/2016 Zur Ausgabe

President‘s Corner (Mitteilungen der Deutschen Schmerzgesellschaft e. V.)

President‘s Corner (Mitteilungen der Deutschen Schmerzgesellschaft e. V.)

Mitteilungen der Österreichischen Schmerzgesellschaft

Mitteilungen der Österreichischen Schmerzgesellschaft